Location: Home
  • search
  • go
  • Relate News
  • 1/14/2021Reform Has Unleashed Chinese Drugs Innovation Boom, Though Some Pharma...
  • 1/14/2021What Do Novartis Deal, PD-1 Competition In China Mean For Tislelizumab...
  • 1/14/2021Pharma Companies to Cut Prices of News Drugs by 51% to Access Chinese ...
  • 1/14/2021Novartis, Once Wary of Chinese M&A, Dives into BeiGene's Cancer Immuno...
  • 1/13/2021NMPA Issues the Measures for Post Marketing Changes of Drug Products
  • 1/13/2021Domestic PD-1s in the 2020 NRDL Negotiated Entry: Winners Take All
  • 1/13/2021PharmCube: Top 15 Innovative Drug In-licensing Deals by Chinese Pharma...
  • 1/13/2021Sesen Bio and Qilu Pharma Announce Acceptance IND for Vicineum  in C...
  • 1/13/2021BeiGene Granted Chinese Approval of Tislelizumab in Combo with Chemoth...
  • 1/13/2021Gracell Approved to Begin Phase 1/2 Trial of CAR-T GC007g for Leukem...
  • 1/12/2021Qilian International Debuts on Nasdaq
  • 1/12/2021Swiss Re Sees Short-term Health insurance as Growth Driver in China
  • 1/11/2021VISEN Pharma Closes $150M Series B Financing for Novel Endocrinology D...
  • 1/11/2021Novartis and BeiGene in $2.2B Deal Latter's Promising Checkpoint Inhi...
  • 1/11/2021Chi-Med and Inmagene Announce Partnership for Portfolio of Drug Candi...
  • 1/11/2021Strand Therapeutics and BeiGene Enter into Agreement to Develop Solid ...
  • 1/11/2021Chipscreen Files Pivotal PIII Trial IND Submission for Anticancer Chia...
  • 1/11/2021NHSA Issues Two Interim Rules for Management of BMI Designated Medical...
  • 1/8/2021VISEN Pharma Granted IND Approval for P2 Trial of Achondroplasia Drug...
  • 1/8/2021Allecra and Haini Pharma Enter Licensing Deal for Cefepime/Enmetazob...
  • 1/8/2021Everest Medicines Announces CTA Approval for P3 Trial of Sacituzumab G...
  • 1/8/2021HLB's Liver Cancer Drug Wins Marketing Approval in China
  • 1/8/2021Abbisko Raises $123 Million From Carlyle, Warburg
  • 1/8/2021European Firms Eye Chinese Assets in Mainly Insurance and Healthcare...
  • 1/8/2021Recent Executive Moves
  • 1/8/2021SMCP - Coronavirus in China: 2021 Outlook Brightens for Health Care Op...
  • 1/8/2021S&P Global: China's Big Tech to Continue Disruption of Healthcare Sect...
  • 1/7/2021Economic Burden and Health Care Access for Patients with IBD in China:...
  • 1/7/2021China Issues Announcement on the 2021 Doping List (#51)
  • 1/7/2021Apollomics Granted Breakthrough Therapy Designation for AML Drug APL-1...
  • Page:203/774 Total number of articles:23194: [First][<<] [201] [202] [203] [204] [205] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group